3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes

NCT ID: NCT04601103

Last Updated: 2024-10-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

53 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-06

Study Completion Date

2020-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations. Adverse events will be tracked through study dental examinations and subject diaries with twice daily use of the 3M Oral Rinse used in combination with toothpaste containing one of three levels (no, medium, high) of Sodium Lauryl Sulfate (SLS).

Determine the subjects' acceptance of sloughing and/or other side effects

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Mucosal Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study was designed as an imbalanced 2 Period Crossover Study. However, the study was terminated during the washout period and the results reported here reflect only the period 1 results.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors
Assessors did not know what toothpaste subjects used.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comparator: No SLS Toothpaste

3M Oral Rinse in combination with no SLS toothpaste (A)

Group Type EXPERIMENTAL

No SLS toothpaste

Intervention Type DRUG

Toothpaste no Sodium Lauryl Sulfate

Anti-plaque

Intervention Type DEVICE

Rinse prevents bacterial adherence to teeth

Comparator: Medium SLS Toothpaste

3M Oral Rinse in combination with medium SLS toothpaste (B)

Group Type EXPERIMENTAL

Medium SLS toothpaste

Intervention Type DRUG

Less than or equal to X ppm Sodium Lauryl Sulfate

Anti-plaque

Intervention Type DEVICE

Rinse prevents bacterial adherence to teeth

Comparator: High SLS Toothpaste

3M Oral Rinse in combination with high SLS toothpaste (C)

Group Type EXPERIMENTAL

High SLS toothpaste

Intervention Type DRUG

More than or equal to X ppm Sodium Lauryl Sulfate

Anti-plaque

Intervention Type DEVICE

Rinse prevents bacterial adherence to teeth

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No SLS toothpaste

Toothpaste no Sodium Lauryl Sulfate

Intervention Type DRUG

Medium SLS toothpaste

Less than or equal to X ppm Sodium Lauryl Sulfate

Intervention Type DRUG

High SLS toothpaste

More than or equal to X ppm Sodium Lauryl Sulfate

Intervention Type DRUG

Anti-plaque

Rinse prevents bacterial adherence to teeth

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sensodyne ProNamel Fresh Breath Toothpaste Clinpro Tooth Creme Colgate Cavity Protection Toothpaste 3M Oral Rinse

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Able to understand and willing to sign the informed consent;
2. Willing to agree to maintain confidentiality of the study and study materials;
3. 3M employee aged 18 years and older;
4. Willing to return to the study facility for scheduled study visits and recalls;
5. Agree not to use other oral hygiene products (non-study toothpaste, non-study toothbrush, mouth rinse, chewing gum);
6. Agree to the study instruction and schedule

Exclusion Criteria

7. A member of the Medical Clinical Affairs (MCA) staff or Panda product team for the device under investigation;
8. Have a dental appointment scheduled during study duration for professional cleaning;
9. Is pregnant, nursing, or planning to become pregnant within the study duration;
10. History of antibiotic therapy within the previous 30 days or have a condition that is likely to need antibiotic treatment over the course of the study (e.g., cardiac conditions requiring antibiotic prophylaxis such as heart murmurs, pacemakers, or prosthetic heart valves and prosthetic implants);
11. History of using a prescription antimicrobial mouth rinse during the past 3 months;
12. Currently taking medications which may alter gingival appearance/bleeding;
13. Currently using anticonvulsants, calcium channel blockers, or other medications with side effects known to impact oral health;
14. Participation in any other clinical study within the last 30 days;
15. Resides in the same household with a subject already enrolled in the study;
16. Known history of sensitivity to oral hygiene products;
17. Currently using tobacco products (cigarettes, chewing tobacco) or vaping products (ecigarettes);
18. History of diabetes;
19. Have removable partial/full dentures;
20. Have orthodontic appliances;
21. Have medical or oral conditions that may compromise the subject's safety or interfere with the conduct and outcome of the study;
22. Have known sloughing within the last 3 weeks;
23. Have dry mouth;
24. Have widespread caries or chronic neglect;
25. Have gross pathological changes of oral soft tissues;
26. Have advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive alveolar bone loss);
27. Unsuitable for enrollment in this study based on the professional opinion of the dental examiner based on the oral exam or other reasons not specified in the protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

3M

INDUSTRY

Sponsor Role collaborator

Solventum US LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brenda C Coalwell, BA

Role: PRINCIPAL_INVESTIGATOR

3M Health Care Business Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

3M Health Care

Saint Paul, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EM-11-050043

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anti-gingivitis Mouthrinse
NCT06048627 COMPLETED PHASE3
A Study of Experimental Mouthwashes
NCT05121909 COMPLETED PHASE4
Mouth Rinses for Inactivation of COVID-19
NCT04584684 TERMINATED PHASE2